This list is based on the watchlists of people on Stock Events who follow BETA.NSE. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.
FAQs
What is Beta Drugs stock price today?▼
The current price of BETA.NSE is ₹1,775.10 INR — it has decreased by -1.3% in the past 24 hours. Watch Beta Drugs stock price performance more closely on the chart.
What is Beta Drugs stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on NSE (India) exchange Beta Drugs stocks are traded under the ticker BETA.NSE.
What is Beta Drugs market cap?▼
Today Beta Drugs has the market capitalization of 19.68B
When is the next Beta Drugs earnings date?▼
Beta Drugs is going to release the next earnings report on February 15, 2027.
What is Beta Drugs revenue for the last year?▼
Beta Drugs revenue for the last year amounts to 4.72B INR.
What is Beta Drugs net income for the last year?▼
BETA.NSE net income for the last year is 500M INR.
How many employees does Beta Drugs have?▼
As of November 2, 2026, the company has 455 employees.
In which sector is Beta Drugs located?▼
Beta Drugs operates in the Other sector.
When did Beta Drugs complete a stock split?▼
Beta Drugs has not had any recent stock splits.
Where is Beta Drugs headquartered?▼
Beta Drugs is headquartered in Panchkula, India.